TAXUS ARRIVE: Taxus peri-approval registry: A multi-center safety surveillance program

Trial Profile

TAXUS ARRIVE: Taxus peri-approval registry: A multi-center safety surveillance program

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Nov 2016

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms ARRIVE
  • Sponsors Boston Scientific Corporation
  • Most Recent Events

    • 17 Oct 2008 Two-year results from the diabetic subset analysis presented at the Cardiovascular Research Foundation's Transcatheter Cardiovascular Therapeutics symposium.
    • 13 May 2008 Pooled analysis of 2-year outcomes for 7,492 patients in the ARRIVE 1 and 2 registries reported at EuroPCR 2008.
    • 29 Mar 2008 Pooled analysis of 2-year outcomes for 7,033 patients in the ARRIVE 1 and 2 registries reported at SCAI-ACCi2 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top